225 related articles for article (PubMed ID: 19205557)
1. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
[TBL] [Abstract][Full Text] [Related]
2. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children].
Zeman K; Cywińska-Bernas A
Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547
[TBL] [Abstract][Full Text] [Related]
3. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases.
Ballow M
Cancer; 1991 Sep; 68(6 Suppl):1430-6. PubMed ID: 1878841
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology.
Dourmishev LA; Guleva DV; Miteva LG
Wien Med Wochenschr; 2018 Jun; 168(9-10):213-217. PubMed ID: 28864939
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin therapy in rheumatic diseases.
Bayry J; Negi VS; Kaveri SV
Nat Rev Rheumatol; 2011 Jun; 7(6):349-59. PubMed ID: 21556030
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin therapy for rheumatic diseases.
Sany J
Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
[TBL] [Abstract][Full Text] [Related]
10. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience.
De Vita S; Ferraccioli GF; Di Poi E; Bartoli E; Bombardieri S
Clin Exp Rheumatol; 1996; 14 Suppl 15():S85-92. PubMed ID: 8828953
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
12. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
Wolfe RM; Ang DC
Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.
Lazurova I; Macejova Z; Benhatchi K; Oetterová M; Antolová E; Asherson RA; Rovensky J
Clin Rheumatol; 2007 Dec; 26(12):2145-2147. PubMed ID: 17487450
[TBL] [Abstract][Full Text] [Related]
14. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.
Jordan SC; Toyoda M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):31-8. PubMed ID: 8033432
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
16. [Immunoglobulins and physiopathology: actual indications].
Mouthon L; Guilpain P
Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous immunoglobulin (IVIG)].
Hara M
Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
[TBL] [Abstract][Full Text] [Related]
18. The role of high-dose intravenous immunoglobulin in rheumatology.
Vaitla PM; McDermott EM
Rheumatology (Oxford); 2010 Jun; 49(6):1040-8. PubMed ID: 20179081
[TBL] [Abstract][Full Text] [Related]
19. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
20. Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.
Kamali S; Cefle A; Sayarlioglu M; Gul A; Inanc M; Ocal L; Aral O; Konice M
Rheumatol Int; 2005 Apr; 25(3):211-4. PubMed ID: 14722731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
